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Hepatic stellate cells (HSCs) have been shown to be able to activate T-cells and upregulate expression of surface molecules essential for this
process, when treated with IFN-γ. But little is known about the early molecules expressed by activated hepatic stellate cells under the same
treatment. In this study, we investigate the effect of IFN-γ on the transcription and expression of these early molecules in hepatic stellate cells. We
show on the molecular level that activated rat hepatic stellate cells express the class II transactivator, the invariant chain (CD74), the MHC class II
molecules, as well as cathepsin S, all of which are known to be responsible for the initial steps of successful antigen presentation. The mRNA and
the protein expression level of these molecules is upregulated by IFN-γ. Importantly, IFN-γ increases cathepsin S activity, suggesting a possible
involvement of this protease in CD74 processing. Our data also show that not only can the HSCs take up antigenic proteins, they can also process
them. Our comparative study indicates that the rat HSC-T6 cell line displays sufficient similarity to the activated rat HSCs in order to serve as a
model for in vitro studies on the molecular mechanisms of inflammatory response.
© 2006 Elsevier B.V. All rights reserved.Keywords: Cathepsin S; CIITA; MHC class II; Hepatic stellate cell; Invariant chain; CD741. Introduction
Hepatic stellate cells (HSCs), representing 5–8% of the total
liver cells, are found in the space of Disse of adult livers between
hepatocytes and liver sinusoidal endothelial cells. The classical
functions of HSCs are fat storage, vitamin A uptake and
metabolism. During the past decades, many authors have shown
that HSCs play an important role in defending liver from injuries
and at the same time are mediators of hepatic fibrosis by producing
profibrotic cytokines and extracellular matrix proteins [1–3]. These
different functions of hepatic stellate cells are tightly linked to their
transition from a quiescent to an activated phenotype. Recent
papers showed the antigen presentation capability of the HSCsAbbreviations: HSCs, hepatic stellate cells; CIITA, class II transactivator;
IFN-γ, interferon gamma; DC, dendritic cells; APCs, antigen presenting cells;
CLIP, class II associated li-peptide; AFC, 7-amino-4-trifluoromethyl coumarin
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doi:10.1016/j.bbamcr.2006.11.005[4,5]. This finding is important as most cell types of the liver
contribute to the immune response of the liver in different ways.
Hepatocytes produce acute phase proteins [6,7] and liver sinusoidal
endothelial cells induce tolerance [8]. The Kupffer cells, resident
macrophages of the liver, and resident dendritic cells are known
professional antigen-presenting cells [9–13]. The studies from
Viñas et al. [4] and Yu et al. [5] described the presence of surface
molecules (HLA-DR) and co-molecules (CD40, CD80, CD86),
which are necessary for antigen presentation to the T-cells, on the
HSCs. In particular, these surface molecules and co-molecules are
upregulated when the HSCs are treated with IFN-γ. It was further
demonstrated that the HSCs were capable of inducing T-cell
proliferation, although less efficiently when compared to the
professional antigen presenting cells (APCs), such as Kupffer or
dendritic cells, of the liver.
Antigen presentation via MHC class II is a complex process.
The early stage of this process involves the induction of the
class II transactivator (CIITA), which is the ‘master regulator’ of
the MHC class II expression. CIITA is known to respond to
different proinflammatory stimuli and to induce the expression
Table 1
RT-PCR primer
Primer Annealing (°C) Sequence Length (bp)
sCathepsin S 55 5′-ACCGAGAATATGAATCATGGTG-3′ 127
asCathepsin S 5′-TTCTCGCCATCCGAATATATCC-3′
sCD74 59 5′-TGGACCCGTGAACTACCCACAGC-3′ 234
asCD74 5′-ATATCCTGCTTGGTCACTCC-3′
sRT1-Bα 55 5′-TCGCCCTGACCACCATGCTCAGCC-3′ 187
asRT1-Bα 5′-TCGGGGATCCTCCAGATGGT-3′
sRT1-Dα 55 5′-TCCCCTCCAGCGGTCAATGTC-3′ 259
asRT1-Dα 5′-ACCCGAGAACACACAGGACATTC-3′
sCIITA type I 55 5′-ACCATTGTGCCCTGCTTC-3′ 243
sCIITA type III 52.4 5′-ATCACTCCTCTCTTTACATCATGC-3′ 130
sCIITA type IV 55 5′-TAGCGGCAGGGAGACTAC-3′ 141
asCIITA type I, III, IV 5′-GGTCAGCATCACTGTTAAGGA-3′
sβ-actin 55 5′-TTCTACAATGAGCTGCGTGTGG-3 332
asβ-actin 5′-AAGCTGTAGCCACGCTCGG-3′
sCathepsin L 55 5′-CACCAGTGGAAGTCCACA-3′ 122
asCathepsin L 5′-TTCCCGTTGCTGTACTCCCC-3′
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as the accessory molecule invariant chain (CD74, also known as
li-chain) (for review see [14]). After the induction, the assembly
of class II molecules (RT1-Bα and β, RT1-Dα and β) with the
CD74, a type II membrane protein, occurs followed by the step-
wise processing of the CD74 into the CLIP (class II associated
li-peptide) starting from the C-terminus. The invariant chain
directs the MHC class II complex to the late endocytic
compartment and prevents the premature loading of theFig. 1. Identification of primary rat hepatic stellate cells stained with HSC markers.
cover slips with (A) GFAP (green); (B) Desmin (green); (C) SMAA (red). (D) The SM
(A) to (C) were counterstained with DAPI (blue). Scale bar=10 μm.antigen-binding groove. There are many different proteases
involved in the processing of CD74. The most effective
proteases involved in the last step of this process are cathepsins
S and L. These enzymes release the CLIP from the lip10
(leupeptin induced polypeptide). Depending on the cell type,
cathepsin L and cathepsin S are involved in this step-wise
degradation of the invariant chain in thymic epithelial cells [15]
and in B-cells, macrophages and dendritic cells [16–18]
respectively.Cells isolated from Wistar rats were labeled after 3 days of cultivation on glass
AA staining (red) at day ten after isolation showed prominent fiber-like features.
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inflammation and the role of hepatic stellate cells in fibrosis is
undoubted. In order to search for new targets for a successful
treatment, we address the questions: Are these early molecules
of antigen presentation and specifically cathepsin S expressed in
hepatic stellate cells and are they responsive to the proin-
flammatory cytokine, IFN-γ. If so, we hypothesize that
cathepsin S could be involved in the degradation of the invariant
chain in activated hepatic stellate cells. We were also curious to
know whether there is any differential expression of these
molecules depending on the activation history of HSCs. In case
of differentially expressed molecules, they could become a new
target for antifibrotic treatment.2. Materials and methods
2.1. Isolation of primary HSCs
The primary HSCs were isolated from Wistar rats according to a previously
published protocol [19]. Briefly, the supernatant was centrifuged at 50×g for
5 min for several rounds until no visible pellet was observed. The next
centrifugation step at 200×g for 10 min yielded a pellet containing the HSCs.Fig. 2. OneStep RT-PCR analysis of key molecules involved in the early steps of ant
HSCs cultured for 36 days (B) and CFSC-3H (C) was analyzed by RT-PCR using p
invariant chain (CD74), 4: RT1-Bα, 5: RT1-Dα, 6: CIITA type IV, 7: CIITA type III, a
sequencing. Because we did not detect the mRNA for CIITA types III and IV in CF
important molecules involved in the early stage of antigen presentation are expresseThis pellet was washed once in culture medium and recovered by centrifugation.
The cells were re-suspended in culture medium and seeded into 75 cm2 culture
flasks. For immunocytochemistry, some cells were plated onto glass cover slips
in a 24-well culture plate.
2.2. Cell culture
The rat HSC cell line HSC-T6 [20] was a gift from Dr. Scott Friedman
(Mount Sinai School of Medicine in New York). The cell line CFSC-3H was
kindly provided by Dr. Marcus Rojkind at Albert Einstein College of Medicine,
Bronx, New York. The HSC cell lines and the primary rat HSCs were routinely
cultured in DMEM (Dulbecco's Modified Eagle Medium), supplemented with
10% FBS and 100 U penicillin/100 μg/ml streptomycin at 37 °C in a humidified
atmosphere of 5% CO2. The HSC cell lines were split twice a week in a 1:3 ratio
by trypsinization (0.05% trypsin/0.53 mM EDTA). The primary cells were
passaged when required. The primary cells used in all experiments are cell
culture activated. All the cell culture media and reagents were purchased from
Invitrogen (CA, USA).
2.3. IFN-γ treatment and RNA isolation
HSC-T6, CFSC-3H and activated HSCs were plated into 75 cm2 culture
flasks and grown overnight at conditions described above. The cells at a
confluence of 60–70% were incubated with 10 ng/ml final concentration
(equivalent to 100 U/ml) of recombinant rat IFN-γ for 2, 4, 8 and 24 h. Theigen presentation. Total RNA extracted from the HSC-T6 cell line (A), primary
rimers indicated in Table 1. Lane 1: 100 bp MW ladder (bp), 2: cathepsin S, 3:
nd 8: β-actin. All products detected had the expected size and were confirmed by
SC-3H, a RT-PCR for CIITA type I was performed (D). This demonstrates that
d in HSCs.
Fig. 3. (A–C) Quantitative analysis of the change in cathepsin S, CIITA, CD74 and RT1-Dα transcript level upon treatment with IFN-γ using real-time RT-PCR. After
treatment with IFN-γ for 2, 4, 8 and 24 h, total RNA was extracted from the three different HSCs (activated HSC, HSC-T6 and CFSC-3H). The RNA was reverse
transcribed and real-time RT-PCR was performed. The results were expressed as fold change in gene expression compared to the untreated samples using the relative
quantification method for HSC-T6 (A), activated HSCs (B) and CFSC-3H (C). The upregulation of all transcripts by IFN-γ is demonstrated for all studied HSCs.
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USA). Total RNA was isolated using the NucleoSpin RNAII isolation kit
(Macherey & Nagel, Germany) according to the manufacturer's protocol. The
RNA concentration was measured with the ND-100 spectrophotometer
(NanoDrop Technologies, DE, USA).
2.4. OneStep RT-PCR
RT-PCR was performed with the OneStep RT-PCR kit from Qiagen
(Germany). 100 ng to 1 μg of total RNA was used in each RT-PCR reaction,
depending on the abundance of the transcript. Table 1 shows the information of
the primers used. The primer concentration used was 0.6 μM as recommended
by the manufacturer. The Q-solution was included in all RT-PCR reactions to
minimize nonspecific products. The RT step was carried out for 30 min at 42 °C
and followed by deactivation for 15 min at 95 °C. Conditions for PCR were as
follow: 10 s for denaturation at 94 °C, 10 s for annealing at an appropriate
temperature, and 19 s for synthesis at 72 °C. A total of 40 cycles were
performed. We used the PTC-200 thermal cycler (MJ Research, FL, USA). The
products were analyzed by electrophoresis in a 3% agarose gel and visualized
with ethidium bromide staining. A 100 bp DNA ladder (SM0242, Fermentas,
Lithuania) was used as a size marker in all gels. DNA sequencing confirmed the
identity of all PCR products. Sequencing service was performed by Research
Biolabs Singapore.
2.5. Reverse transcription and Real-time PCR of Cat S, Cat L, CD74,
CIITA and RT1-Dα
Real-time PCR was performed using the ABI 7500 Real Time PCR
System (Applied Biosystems, CA, USA). All reagents were purchased from
this company unless otherwise stated. Total RNA was reverse transcribed tocDNA using reagents from the cDNA archive kit (4322171). 10 μg of total
RNA was used in a total reverse transcription reaction volume of 100 μl. The
RT step was performed for 10 min at 25 °C and 2 h at 37 °C. In real-time
PCR, 20× TaqMan gene expression assay mix of Cat S (Rn01534427_m1),
Cat L (Rn00565793_m1), CD74 (Rn01491430_g1), CIITA (Rn01424723_g1)
and RT1-Dα (Rn02346209_g1), as well as 20× 18s rRNA (4319413E) were
used. For each real-time target, the reaction comprises of 3 μl cDNA, 0.5 μl
20× 18S rRNA, 0.5 μl 20× TaqMan gene expression assay, 1 μl nuclease-free
water and 5 μl TaqMan Universal PCR master mix (4352042). Conditions for
PCR were 2 min 50 °C, 10 min 95 °C and 40 cycles of 15 s 95 °C and 1 min
60 °C. The comparative threshold method was used to quantitate relative
changes of target mRNA (User Bulletin #2, Applied Biosystems). Relative
quantitation of target mRNA was expressed as fold change in gene expression
to control (untreated). The data presented are representative for three
independent experiments with the same trend. The graphs were made using
OrignPro 7 (OriginLab, MA, USA).
2.6. Immunostaining and microscopy
The primary cells were grown in DMEM supplemented with 10% FBS on
glass cover slips in 24-well culture plates prior to staining with antibodies
against GFAP, SMAA, Desmin, RECA-1, ED-2, cathepsin S, RT1-B and CD74.
At 60–70% confluence, the cells were washed once with sterile PBS and fixed
with 4% paraformaldehyde (PFA) for 30 min at 4 °C, followed by three washes
with PBS. The cells were blocked and permeabilized in blocking solution (10%
horse serum, 0.1% Triton X-100 in PBS) for 1 h at 37 °C. The primary antibody
was incubated in 10% blocking solution in PBS for 1 h at 37 °C followed by the
secondary antibody under the same conditions. The primary antibody was
omitted as a negative control. All images were taken with the LEICA DM IRB
epifluorescence microscope using a 63× objective.
Fig. 4. Real-time RT-PCR analysis of the cathepsin L transcript level after IFN-γ
treatment. The cells were treated with IFN-γ for 2, 4, 8 and 24 h, total RNAwas
extracted from activated HSCs, HSC-T6 and CFSC-3H respectively. After
reverse transcription, the cathepsin L mRNA level was analyzed using real-time
RT-PCR. Using the relative quantification method, the results were expressed as
fold change in gene expression compared to the untreated samples. The graphs
illustrate the lack of change in cathepsin L mRNA level after treatment with
IFN-γ.
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confluence and the cells were cultivated further for different times depending on
the targets to be stained (Cat S: 0, 4, 8, 24, 30 h; CD74: 0, 8, 24, 30 h; and RT1-B:
0, 24, 48 h). The presented images are representative for 3 experiments. Images
were takenwith a 40× objective. The fluorescence intensities from 3 to 7 different
fields of vision of one representative experiment were quantified using the Image
processing toolbox of the MATLAB platform (MathWorks, MA, USA).
The following antibodies were used in the immunofluorescent staining.
Anti-Cat S antibody (sc-6505) and anti-CD74 antibody (sc-5438) were from
Santa Cruz Biotechnology (CA, USA); anti-RT1-B antibody (554926) was from
BD Pharmingen (CA, USA); anti-GFAP antibody (Z 0334) was from Dako (CA,
USA); and anti-SMAA (smooth muscle alpha-actin)-Cy3 (C 6198) and anti-
desmin antibody (D 8281) were from Sigma Chemicals (MO, USA). The anti-
RECA-1 antibody (MCA970) and anti-ED-2 (CD163, MCA342R) were from
Serotec (Oxford, UK). The secondary antibodies used were anti-goat-Alexa488
(A-21467, Invitrogen), anti-rabbit-FITC (F 0382, Sigma) and anti-mouse-FITC
(F 0257, Sigma).
2.7. Cathepsin S activity measurement
The cells were grown in cell culture medium containing 10% FBS in
75 cm2 flasks. When the cells reached 50–60% confluence, IFN-γ was added
at 10 ng/ml or omitted as untreated sample. The cells were harvested 48 h
later and resuspended in CS cell lysis buffer. Cathepsin S activity was
measured using a kit from BioVision (K1101-01) according to the provided
manual. The final substrate concentration was 200 μM. Emitted fluorescence
was measured using the Tecan Safire II (Tecan, Zurich, Switzerland)
fluorescence plate reader at λex: 400 nm and λem: 505 nm. An AFC standard
curve was used to calculate the released fluorophore in μM per μg protein per
hour at 37 °C.
2.8. Antigen uptake and processing experiment
The cells were grown to 70% confluence and incubated with 100 μg/ml DQ-
ovalbumin (Invitrogen) for 15 min at 37 °C or 4 °C (control) and then washed
twice with medium. The cells were further incubated at 37 °C and mounted onto
microscope slides after different time points. The uptake and digest of the tracer
ovalbumin was imaged with the LEICA DM IRB epifluorescence microscope
using the FITC filter. Representative images of 3 independent experiments were
shown.
3. Results
3.1. HSC isolation and characterization
Primary HSCs were isolated from Wistar rat livers according
to a previously published protocol [19], and seeded into 75 cm2
culture flasks or onto glass cover slips. At the same time, part of
the cell pellet was also used for total RNA isolation. To confirm
the HSC identity, primary cells cultured for 3 days were stained
with antibodies against GFAP, desmin, and SMAA respectively.
As illustrated in Fig. 1, cells in short-term (3 days) culture
displayed prominent filamentous GFAP staining (Fig. 1A) in
numerous (but not all) cells, along with staining for two other
HSC markers, desmin (Fig. 1B) and SMAA (Fig. 1C). In the
subsequent 7 days, the cells gradually lost the strong
filamentous GFAP staining (data not shown). At the same
time, cells acquired very pronounced SMAA staining, with a
typical filamentous distribution. Notably the intense SMAA
staining even extended to the nucleus (Fig. 1D), suggesting that
the HSCs are at a highly activated state. The purity of our HSC
preparation was estimated to be greater than 95% according to
GFAP positive staining (data not shown). In addition, the cellswere stained negative for RECA-1 antigen, a marker for
endothelial cells. A small percentage of cells stained positive for
ED-2 (CD163), a Kupffer cell marker, within the first few days
(data not shown). In order to confirm that the activated HSCs
used in our study were not contaminated by Kupffer cells we
performed a RT-PCR using primers for a specific Kupffer cell
marker (77- to 88-kDa fucose receptor). The RT-PCR could not
detect this marker within 30 cycles (data not shown).
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antigen presentation in HSCs
In order to investigate whether HSCs express the main
molecules required in the beginning of antigen presentation at
the transcriptional level, specific RT-PCR primer pairs (Table 1)
were designed. The molecules studied included the class II
transactivator (CIITA), which is the major transcriptional
regulator of MHC class II molecules, being a transcriptional
co-activator; the MHC class II molecules (RT1-Dα and RT1-
Bα) themselves; the invariant chain (CD74), a chaperone for the
MHC class II molecules, and cathepsin S, which is a lysosomal
protease predominantly expressed in antigen presenting cells
and lymphatic tissues, and has been implicated in the processing
of the invariant chain in certain cell types [16–18]. We included
an established cell line derived from a CCl4-induced fibrotic
liver in our study in order to investigate whether a different
history of activation makes a difference with respect to the
expression of the studied molecules. Total RNA were isolated
from primary HSCs that had been culture activated for 36 days,
as well as from the HSC-T6 and CFSC-3H cell lines cultured in
the absence of IFN-γ. As shown in Fig. 2, the activated HSCs
and both cell lines had the same expression pattern for Cat S,Fig. 5. Effect of IFN-γ treatment on the expression of CD74 in HSC-T6 cells and activ
of 60–70% overnight at conditions described inMaterials and methods. The cells were
immunofluorescence staining with anti-CD74 antibody after 30 h of IFN-γ inductio
fluorescence). (B) and (D) displayed the controls without IFN-γ for HSC-T6 and a
bar=10 μm.CD74, RT1-Bα and RT1-Dα and showed a basal transcript
level of these molecules.
Interestingly, both type IV CIITA, (known as the major
IFN-γ inducible transactivator [21]) and type III CIITA
(known to regulate the constitutive class II expression in B-
cells [22]) were expressed in activated HSCs, as well as in
HSC-T6 (Fig. 2A and B), but not in CFSC-3H (Fig. 2C).
Because we were unable to detect the CIITA types III and IV
in the CFSC-3H cell line, we tested whether they are ex-
pressing the type I. Indeed we found the sole expression of
type I in this cell line (Fig. 2D). In contrast, type I was not
expressed in HSC-T6 and activated HSCs (data not shown).
Noteworthy is also that the expression of cathepsin S [23] and
CIITA type III [24] was shown for gliomas.
The mRNA for cathepsin L, another lysosomal cysteine
protease, which could be involved in the CD74 processing, was
present in all cells used (data not shown).
3.3. Quantitative analysis of IFN-γ effect on mRNA transcripts
of Cat S, Cat L, CD74, CIITA and RT1-Dα
Initial experiments, using OneStep RT-PCR, established
that the above mentioned molecules were expressed inated HSCs. HSC-T6 and activated HSCs were plated and grown to a confluence
treated with IFN-γ for a different period of time. Images (A) and (C) showed the
n for HSC-T6 and activated HSCs respectively (Arrows depict the increase in
ctivated HSCs respectively. Cells were counterstained with DAPI (blue). Scale
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their response towards treatment with the proinflammatory
cytokine IFN-γ. The transcripts for CIITA, CD74, RT1-Dα
and Cat S were detected by quantitative real-time RT-PCR
using Taqman assays (Fig. 3A–C) and are presented as fold
change in gene expression relative to the untreated sample.
Upon induction with IFN-γ, we observed that the CIITA (note
that the Taqman assay detects all variants) and the cathepsin S
transcripts in HSC-T6 (Fig. 3A), activated HSCs (Fig. 3B) and
CFSC-3H (Fig. 3C) started to increase at an early time point,
which was in general agreement with earlier observations
[25,26]. While the increase in the CIITA transcript level was
similar in HSC-T6 and CFSC-3H, it was more then 20 times
higher in activated HSCs. Even though the cathepsin S
transcription was upregulated by IFN-γ (somewhat slower for
the HSC-T6), there is an order of magnitude difference in the
change of the mRNA level in the following order HSC-
T6<activated HSC<CFSC-3H.
As expected, the mRNA expression of the MHC class II
molecule (RT1-Dα), and the invariant chain (CD74) were also
induced, but indirectly through the subsequent action of CIITA
at a later time. This type of activation by CIITA is reviewed in
[27]. As can be seen from the graphs (Fig. 3A–C), the foldFig. 6. IFN-γ effect on the expression of MHC class II molecule RT1-B in HSC-T6
confluence of 60–70% overnight at conditions described. The cells were treated w
methods. Images (A) and (C) showed the immunofluorescence of the anti-RT1-B a
(Arrows show the increase in immunofluorescence). In (B) and (D) are the respective
Scale bar=10 μm.change in gene expression for CD74 and RT1-Dα compared to
the control is much lower in HSC-T6 than in activated HSCs
and CFSC-3H. The difference is about 10 to 20 times.
We knew from initial experiments that cathepsin L is
expressed in activated HSCs, HSC-T6 and CFSC-3H. Because
cathepsin L is used in the thymus for the processing of CD74,
we wanted to see if the cathepsin L mRNA is upregulated in
hepatic stellate cells. Contrary to the observation for cathepsin
S, IFN-γ treatment had no influence on cathepsin L mRNA
level. In fact, after 8 h, the cathepsin L mRNA expression
decreased in CFSC-3H (Fig. 4).
3.4. Upregulation of CD74, RT1-B and cathepsin S proteins
In order to show that the increase in mRNA level also
reflects an increase in protein expression, immunofluores-
cence staining was used to assess the respective proteins in
both the untreated and IFN-γ treated cells at different time
points. For these experiments, we used the HSC-T6 and the
activated HSCs. Upregulation of CD74 expression under IFN-
γ treatment was observed for HSC-T6 (Fig. 5A) and activated
HSCs (Fig. 5C). CD74 expression was significantly induced
by IFN-γ after 30 h, as shown by arrows in the micrographs,and activated HSCs. HSC-T6 and activated HSCs were plated and grown to a
ith IFN-γ for 48 h and immunologically stained as described in Materials and
ntibody after 48 h of induction, for HSC-T6 and activated HSCs respectively
controls without addition of IFN-γ. Cells were counterstained with DAPI (blue).
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is consistent with the trafficking pattern of membrane-targeted
proteins. On the contrary, HSCs under untreated conditions
showed a much weaker or barely detectable staining of CD74
(Fig. 5B, D). Similarly, the expression of RT1-B in both the
HSC-T6 cell line (Fig. 6A) and activated HSCs (Fig. 6C) was
also induced after 48 h of IFN-γ treatment. Newly
synthesized RT1-B proteins were visible in the perinuclear
region (depicted by arrows). This observation is consistent
with ER/Golgi localization. Interestingly the immunofluores-
cence staining for CD74 and RT1-B was never homogenously
distributed over the cells, which leads us to the assumption of
heterogeneity among the HSC population regarding their
inducibility by IFN-γ.
We have shown earlier on that there was an increase in the
cathepsin S mRNA in HSC-T6 and activated HSCs treated with
IFN-γ (Fig. 3A, B). At first it seems that our immunofluorescent
approach failed to convincingly document an induction in
cathepsin S at the antigen level at 8 h respectively for HSC-T6
and activated HSCs (Fig. 7A, C). However, quantification of the
fluorescence intensities from different areas of the same
experiment showed that IFN-γ resulted also in a significant
increase in cathepsin S expression on the protein level for HSC-
T6 and the activated HSCs (Fig. 8).Fig. 7. Expression of cathepsin S in the IFN-γ treated and untreated HSC-T6 and activ
of 60–70% overnight at conditions described. The cells were treated with IFN-γ for
Images (A) and (C) represented the immunofluorescence with anti-cathepsin S an
respectively. Images (B) and (D) are the corresponding controls for the HSC-T6 and3.5. Cathepsin S activity upon induction with IFN-γ
To further investigate the induction of cathepsin S by IFN-γ,
activity measurement was performed to directly detect cathe-
psin S in activated HSCs and both cell lines. There was a
significant increase of cathepsin S specific activity in HSC-T6,
activated HSCs and CFSC-3H (P<0.05) after 48 h (Fig. 9). This
activity was almost completely inhibited by the cathepsin S
inhibitor provided with the kit (data not shown).
3.6. Uptake and processing of ovalbumin
Successful antigen presentation requires the HSCs to
internalize antigenic proteins and to process them into smaller
peptides. To demonstrate these capabilities of activated HSCs
and HSC-T6, a quenched tracer DQ-ovalbumin was used in the
experiments. DQ-ovalbumin is strongly labeled with the
fluorescent BODIPY FL dye, whereby the fluorescence is
quenched in the intact ovalbumin protein. Upon digestion into
peptides, the fluorescence is released and can be detected with a
standard fluorescein optical filter. The uptake of ovalbumin was
thought to occur through receptor-mediated endocytosis by the
Mannose receptor [28,29]. In our case, the HSCs (activated
HSCs as well as HSC-T6) took up the ovalbumin and processedated HSCs. HSC-T6 and activated HSCs were plated and grown to a confluence
8 h and stained by immunofluorescence as described in Materials and methods.
tibody after 8 h of incubation with IFN-γ for HSC-T6 and activated HSCs
activated HSCs. Cells were counterstained with DAPI (blue). Scale bar=10 μm.
Fig. 8. Quantification of the fluorescence intensities. Several fields of vision were used to quantify the total fluorescence with a boundary to the nuclei. The values were
normalized to the area. Data are presented as mean±SD *P<0.05, #P<0.1.
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time of 30 min, a shift in the fluorescence emission from green to
orange became apparent as shown in Fig. 10. This shift was due
to the formation of so-called excimer at spots with highly
localized and concentrated digested peptide tracer, as described
in the manufacturer's instructions. The activated HSCs showed aFig. 9. Cathepsin S activity in activated HSCs and two different cell lines. The
cells were grown in cell culture medium containing 10% FBS. When they
reached 50–60% confluence, IFN-γ was added or omitted as control. The cells
were harvested 48 h later and resuspended in CS cell lysis buffer. Cathepsin S
activity was measured using a final substrate concentration of 200 μM. The
specific activity is given in released fluorophore (AFC) in μM per μg protein per
hour at 37 °C. Data are presented as mean±SD *P<0.05.very strong green-yellow autofluorescence around the nucleus.
As a result, the green dots were not detectable, but orange stained
vesicles became discernable after 30 min of incubation. This
shows not only the uptake but also the successful processing of
the antigen.
4. Discussion
Recently published papers demonstrated by flow cytometric
analysis that the MHC class II molecule (HLA-DR), and co-
stimulatory molecules (such as CD40, CD80 and CD86) can be
stimulated by IFN-γ in HSCs [4,5]. However, no information
was available concerning the early events of antigen presenta-
tion and about the molecules involved in these events. Among
them, CIITA type IV the transactivator of class II molecules is
considered as a ‘major regulator’ for other molecules, like MHC
class II molecules and invariant chain (CD74), and is responsive
to IFN-γ [14,27]. Furthermore, the invariant chain was known
to be involved in the assembly of the MHC class II molecules
[30]. As the invariant chain is blocking the antigen-binding
pocket of the class II molecule, it has to be degraded by
proteases. Two of the proteases involved in the processing are
cathepsin L and cathepsin S, which participate, depending on
the cell type [15–18], in the latter steps of degradation of the
invariant chain.
The aim of the current study was to obtain more detailed
information on the molecular mechanisms underlying antigen
Fig. 10. Uptake and processing of labeled ovalbumin. The cells were initially
incubated with DQ-ovalbumin for 15 min at 37 °C and then washed twice with
medium. Subsequently the cells were incubated in medium alone for an
additional 30 min, and imaged with a Leica epifluorescence microscope. The
images showed the uptake and digest of the DQ-ovalbumin by HSC-T6 and
activated HSCs respectively. Arrows referred to the red-shifted excimer formed
by high concentrations of digested ovalbumin. Scale bar=10 μm.
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immunofluorescence methods were employed to study the
molecules involved in the early stage of antigen presentation.
Along with culture activated HSCs, we used in our study two
cell lines. The HSC-T6 is a SV40 immortalized HSC cell line,
regarded as semi-activated, whereas the CFSC-3H is derived
from a cirrhotic liver and is regarded as in vivo activated. For
the first time, we showed that activated HSCs, as well as the
HSC cell lines HSC-T6 and CFSC-3H expressed transcripts
for all molecules studied, namely CIITA, RT1-Bα, RT1-Dα,
CD74, and cathepsin S (Fig. 2A–C). Interestingly we found
that in addition to CIITA type IV (common to non-
professional APCs), the CIITA type III was also expressed
in HSCs. The transcript for CIITA type III was clearly
detectable in activated HSCs and the HSC-T6 cell line, but not
in CFSC-3H (Fig. 2A–C). This finding was particularly
interesting as CIITA type III has been reported in another
publication [31] to be induced by IFN-γ and subsequently
mediated the repression of collagen (col1a2) in fibroblasts. We
also discovered in the current study that the type III transcript
in the HSCs was inducible by IFN-γ (data not shown). There
could be some relationship between the expression of CIITA
type III and the regulation of collagen expression in hepatic
stellate cells. For the CFSC-3H we found solely the expression
from the CIITA promoter type I (Fig. 2D). This type of CIITAis expressed in dendritic cells and IFN-γ induced macrophages
[14]. Whether this switch between the different CIITA
promoters is a representation of the collagen production in
fibrotic HSCs has to be studied. We did not pursue the
question of the different expression of CIITA in this study,
although this finding has potential in the perspective of the
treatment of fibrotic HSCs.
Apparently CIITA, being the master regulator for the MHC
class II expression, was responding as expected. The increase in
mRNA level started early after addition of IFN-γ (Fig. 3A–C).
The CIITA mediates the IFN-γ effect as shown by Steimle et al.
[21] and induced the increase in the mRNA levels of the MHC
class II molecules and the invariant chain (CD74) as visualized
at the later time-points (Fig. 3A–C). The immunofluorescence
data for the CD74 and RT1-B molecules (Figs. 5 and 6) were in
accordance with the quantitative RT-PCR data. The invariant
chain was detectable after 24 h, but the difference in its
expression between treated sample and control was best seen
after 30 h (Fig. 5A, C). RT1-B expression however, was best
detectable after 48 h (Fig. 6A, C). We quantified the
fluorescence images and found a significant difference in the
fluorescence intensities when comparing IFN-γ treated and
untreated samples (Fig. 8).
The best studied function of cathepsin S is the processing of
the invariant chain by releasing the CLIP from lip10 [18].
Therefore the finding that cathepsin S is expressed in HSCs and
can be upregulated with the proinflammatory cytokine IFN-γ
(Figs. 3A–C and 7) seems to suggest a possible contribution to
the CD74 processing. This is substantiated by the increase in
cathepsin S activity compared to the control (Fig. 9). On the
other hand, cathepsin L which is another possible candidate for
the final processing of the invariant chain [15], showed no
significant increase on the transcription level (Fig. 4). These
results present the first indication towards a role of cathepsin S
in HSCs. In order to conclude the involvement of cathepsin S in
the processing of the invariant chain in HSCs, further studies are
required.
While we investigated the response of CIITA, CD74, RT1-
Dα and cathepsin S to IFN-γ using quantitative real-time PCR,
we made another remarkable finding. Although the expression
of these molecules increased after induction with IFN-γ, there
were differences in the degree of their upregulation for the
different HSCs (Fig. 3A–C). This phenomenon could be
explained by the different basal expression of these molecules.
The differences in origin of these cells, (cell culture activated
HSCs, SV40 immortalization HSC-T6 and derivation from
cirrhotic liver CFSC-3H) could also have an influence on the
expression level. The stability of the transcripts could be
differentially regulated in the various HSCs studied.
Finally we showed that the hepatic stellate cells were
capable of taking up antigenic proteins such as ovalbumin.
More importantly, HSCs also own the molecular machinery
needed to process them into smaller peptides (Fig. 10). The
efficiency of this process was comparable in HSC-T6 and
activated HSCs.
In conclusion, we have shown that activated hepatic stellate
cells feature all molecules necessary for the early stage of
230 G. Maubach et al. / Biochimica et Biophysica Acta 1773 (2007) 219–231antigen presentation. Furthermore, the HSCs are able to
upregulate these molecules in response to IFN-γ, independent
of their origin of activation. There was however a difference in
the degree of upregulation. Another significant finding is that
cathepsin S, a lysosomal cysteine protease primarily involved in
the processing of CD74, was found in HSCs. This is important
because this enzyme is a main target in treating autoimmune
diseases [32] and seems to be involved in angiogenic processes
[33,34]. In order to define the intrinsic role of cathepsin S in
HSCs, more investigations have to be done. But it became clear
from this study that the lysosomal protein degradation is not the
only function of cathepsin S. The finding that different CIITA
promoters are used in HSC-T6, activated HSCs and the fibrotic
CFSC-3H could point to another therapeutic target specific for
fibrotic HSCs.We have also compared the HSC-T6 cell line with
culture activated HSCs and concluded that this cell line retained
many of the key features of the activated cells regarding antigen
presentation. This cell line is thus suited for studying the
molecular events that occurred during antigen presentation in
HSCs.
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